Findings indicate that excessive somatostatin inhibits glucagon secretion in type 1 diabetes, offering a novel target for hypoglycemia management strategies.
Novel deep learning model to assess Alzheimer’s disease progression risk
Patterns in the Alzheimer’s disease (AD) trajectory using Mendelian randomization (MR) and deep learning (DL).